USP25 Promotes Glycolysis of Acute Myeloid Leukemia Cells and Enhances Tumor Immunity
By: Nianxue Wang, Can Yang, Ruya Zhang, Wei Ren and Biao Shen
References
- Bensinger SJ, Christofk HR (2012) New aspects of the warburg effect in cancer cell biology. Semin Cell Dev Biol 23:352–361.
https://doi.org/10.1016/j.semcdb.2012.02.003 - Brondfield S, Umesh S, Corella A et al. (2015) Direct and indirect targeting of MYC to treat acute myeloid leukemia. Cancer Chemother Pharmacol 76:35–46.
https://doi.org/10.1007/s00280-015-2766-z - Cai C, Ma H, Peng J et al. (2023) USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat Commun 14:3648.
https://doi.org/10.1038/s41467-023-39412-6 - Carabet LA, Rennie PS, Cherkasov A (2018) Therapeutic inhibition of Myc in cancer. Structural bases and computer-aided drug discovery approaches. Int J Mol Sci 20:120.
https://doi.org/10.3390/ijms20010120 - Cascone T, McKenzie JA, Mbofung RM et al. (2018) Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab 27:977–987.e4.
https://doi.org/10.1016/j.cmet.2018.02.024 - Chang CH, Qiu J, O'Sullivan D et al. (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162:1229–1241.
https://doi.org/10.1016/j.cell.2015.08.016 - Chen L, Wang Y, Hu Q et al. (2023) Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment. Front Immunol 14:1225948.
https://doi.org/10.3389/fimmu.2023.1225948 - Damiani D, Tiribelli M (2022) Present and future role of immune targets in acute myeloid leukemia. Cancers 15:253.
https://doi.org/10.3390/cancers15010253 - Dembitz V, Gallipoli P (2021) The role of metabolism in the development of personalized therapies in acute myeloid leukemia. Front Oncol 11:665291.
https://doi.org/10.3389/fonc.2021.665291 - Deng S, Zhou H, Xiong R et al. (2007) Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. Breast Cancer Res Treat 104:21–30.
https://doi.org/10.1007/s10549-006-9393-7 - Denuc A, Bosch-Comas A, Gonzàlez-Duarte R et al. (2009) The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS One 4:e5571.
https://doi.org/10.1371/journal.pone.0005571 - Döhner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373:1136–1152.
https://doi.org/10.1056/NEJMra1406184 - Dong Y, Han Y, Huang Y et al. (2020) PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia. Front Immunol 11:1710.
https://doi.org/10.3389/fimmu.2020.01710 - Dong LH, Huang JJ, Zu P et al. (2021) CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia. Environ Toxicol 36:1288–1302.
https://doi.org/10.1002/tox.23126 - Fang D, Lu G (2020) Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma. Ann Transl Med 8:1293.
https://doi.org/10.21037/atm-20-6197 - Fogarty S, Hardie DG (2010) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804:581–591.
https://doi.org/10.1016/j.bbapap.2009.09.012 - Geng C, Pang S, Ye R et al. (2023) Glycolysis-based drug delivery nanosystems for therapeutic use in tumors and applications. Biomed Pharmacother 165:115009.
https://doi.org/10.1016/j.biopha.2023.115009 - Gu S, Hou Y, Dovat K et al. (2023) Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia. Exp Hematol Oncol 12:23.
https://doi.org/10.1186/s40164-023-00383-5 - Hardie DG (2011) AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans 39:1–13.
https://doi.org/10.1042/bst0390001 - He M, Zhou Z, Wu G et al. (2017) Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication. Pharmacol Ther 177:96–107.
https://doi.org/10.1016/j.pharmthera.2017.03.001 - Iorgulescu JB, Braun D, Oliveira G et al. (2018) Acquired mechanisms of immune escape in cancer following immunotherapy. Genome Med 10:87.
https://doi.org/10.1186/s13073-018-0598-2 - Jiang Z, Liu Z, Li M et al. (2019) Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment. EBioMedicine 42:431–442.
https://doi.org/10.1016/j.ebiom.2019.03.068 - Kee Y, Huang TT (2016) Role of deubiquitinating enzymes in DNA repair. Mol Cell Biol 36:524–544.
https://doi.org/10.1128/mcb.00847-15 - Kim SY, Baek KH (2019) TGF-β signaling pathway mediated by deubiquitinating enzymes. Cell Mol Life Sci 76:653–665.
https://doi.org/10.1007/s00018-018-2949-y - Kreitz J, Schönfeld C, Seibert M et al. (2019) Metabolic plasticity of acute myeloid leukemia. Cells 8:805.
https://doi.org/10.3390/cells8080805 - Lapa B, Gonçalves AC, Jorge J et al. (2020) Acute myeloid leukemia sensitivity to metabolic inhibitors: Glycolysis showed to be a better therapeutic target. Med Oncol 37:72.
https://doi.org/10.1007/s12032-020-01394-6 - Li Z, Liu B, Lambertsen KL et al. (2023) USP25 inhibits neuroinflammatory responses after cerebral ischemic stroke by deubiquitinating TAB 2. Adv Sci 10:e2301641.
https://doi.org/10.1002/advs.202301641 - Li J, Tan Q, Yan M et al. (2014) miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer 13:166.
https://doi.org/10.1186/1476-4598-13-166 - Liu Y, Ma J, Lu S et al. (2023) USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway. Chin Med J 136:2229–2242.
https://doi.org/10.1097/cm9.0000000000002714 - Luo H, Li Q, O'Neal J et al. (2005) c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood 106:2452–2461.
https://doi.org/10.1182/blood-2005-02-0734 - Lv H, Liu X, Zhou H (2022) USP25 upregulation boosts GSDMD-mediated pyroptosis of acinar cells in acute pancreatitis. Shock 58:408–416.
https://doi.org/10.1097/shk.0000000000001992 - Manríquez-Olmos L, Garrocho-Rangel A, Pozos-Guillén A et al. (2022) Effect of tricalcium silicate cements in gene expression of COL1A1, MAPK's, and NF-kB, and cell adhesion in primary teeth' pulp fibroblasts. J Clin Pediatr Dent 46:17-24.
http://doi.org/10.22514/jocpd.2022.021 . - Mecklenbrauck R, Heuser M (2023) Resistance to targeted therapies in acute myeloid leukemia. Clin Exp Metastasis 40:33–44.
https://doi.org/10.1007/s10585-022-10189-0 - Miller KD, Fidler-Benaoudia M, Keegan TH et al. (2020) Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin 70:443–459.
https://doi.org/10.3322/caac.21637 - Miller KD, Nogueira L, Devasia T et al. (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72:409–436.
https://doi.org/10.3322/caac.21731 - National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. (2011) Guide for the Care and Use of Laboratory Animals, 8th edn. National Academies Press (US), Washington (DC).
https://doi.org/10.17226/12910 - Nelson JK, Thin MZ, Evan T et al. (2022) USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun 13:2070.
https://doi.org/10.1038/s41467-022-29684-9 - Pan XN, Chen JJ, Wang LX et al. (2014) Inhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiation. PLoS One 9:e105381.
https://doi.org/10.1371/journal.pone.0105381 - Schwartz L, Seyfried T, Alfarouk KO et al. (2017) Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH. Semin Cancer Biol 43: 134–138.
https://doi.org/10.1016/j.semcancer.2017.01.005 - Shibata N, Ohoka N, Tsuji G et al. (2020) Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells. Oncogene 39:3867–3878.
https://doi.org/10.1038/s41388-020-1253-0 - Shimony S, Stahl M, Stone RM. (2025). Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol 100(5):860–891.
https://doi.org/10.1002/ajh.27625 - Siegel RL, Miller KD, Wagle NS et al. (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48.
https://doi.org/10.3322/caac.21763 - Soltani M, Ghanadian M, Ghezelbash B et al. (2023) PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia. BMC Cancer 23:447.
https://doi.org/10.1186/s12885-023-10947-7 - Sun S, Yao M, Yuan L et al. (2021) Long-chain non-coding RNA n337374 relieves symptoms of respiratory syncytial virus-induced asthma by inhibiting dendritic cell maturation via the CD86 and the ERK pathway. Allergol Immunopathol 49: 100–107.
https://doi.org/10.15586/aei.v49i3.85 - Tang B, Luo H, Xie S et al. (2022) Deubiquitination of TNKS1 regulates Wnt/β-catenin to affect the expression of USP25 to promote the progression of glioma. Dis Markers 2022:9087190.
https://doi.org/10.1155/2022/9087190 - Valero R, Marfany G, González-Angulo O et al. (1999) USP25, a novel gene encoding a deubiquitinating enzyme, is located in the gene-poor region 21q11.2. Genomics 62:395–405.
https://doi.org/10.1006/geno.1999.6025 - Vaupel P, Schmidberger H, Mayer A (2019) The Warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol 95:912–919.
https://doi.org/10.1080/09553002.2019.1589653 - Wang XM, Yang C, Zhao Y et al. (2020) The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancer. Nat Cancer 1:811–825.
https://doi.org/10.1038/s43018-020-0089-4 - Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530.
https://doi.org/10.1085/jgp.8.6.519 - Yang H, Liu Y, Yang J et al. (2023a) Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2. Biochem Biophys Res Commun 676:21–29.
https://doi.org/10.1016/j.bbrc.2023.05.111 - Yang X, Wang J (2018) Precision therapy for acute myeloid leukemia. J Hematol Oncol 11:3.
https://doi.org/10.1186/s13045-017-0543-7 - Yang Y, Zhan X, Zhang C et al. (2023b) USP25-PKM2-glycolysis axis contributes to ischemia reperfusion-induced acute kidney injury by promoting M1-like macrophage polarization and pro-inflammatory response. Clin Immunol 251:109279.
https://doi.org/10.1016/j.clim.2023.109279 - Ye B, Zhou H, Chen Y et al. (2023) USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res 132:465–480.
https://doi.org/10.1161/circresaha.122.321849 - Zhao Y, Chen X, Lin Y et al. (2023) USP25 inhibits renal fibrosis by regulating TGFβ-SMAD signaling pathway in Ang II-induced hypertensive mice. Biochim Biophys Acta Mol Basis Dis 1869:166713.
https://doi.org/10.1016/j.bbadis.2023.166713 - Zhong B, Liu X, Wang X et al. (2012) Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat Immunol 13:1110–1117.
https://doi.org/10.1038/ni.2427 - Zhou H, Liu W, Zhou Y et al. (2021) Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia. J Exp Clin Cancer Res 40:353.
https://doi.org/10.1186/s13046-021-02145-9 - Zhu M, Zhang H, Lu F et al. (2021) USP52 inhibits cell proliferation by stabilizing PTEN protein in non-small cell lung cancer. Biosci Rep 41:BSR20210486.
https://doi.org/10.1042/bsr20210486 - Zhu W, Zheng D, Wang D et al. (2021). Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases. Front Cell Dev Biol 9:698751.
https://doi:10.3389/fcell.2021.698751
DOI: https://doi.org/10.2478/aite-2026-0020 | Journal eISSN: 1661-4917
Language: English
Submitted on: Jan 20, 2026
Accepted on: Apr 30, 2026
Published on: Jun 25, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Nianxue Wang, Can Yang, Ruya Zhang, Wei Ren, Biao Shen, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.